Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Other Benefit Plans (Tables)

v3.21.1
Stock-Based Compensation and Other Benefit Plans (Tables)
 3 Months Ended
Mar. 31, 2021
Stock-Based Compensation and Other Benefit Plans [Abstract]  
Summary of Stock-Based Compensation

Three Months Ended March 31,

2021

2020

(in thousands)

Stock-based compensation - equity awards

$

323

$

145

Stock-based compensation - liability awards

1,236

(2,714)

Total stock-based compensation

$

1,559

$

(2,569)
Stock Option Valuation Assumptions

Three Months Ended March 31,

2021

2020

Weighted average exercise price - ($/share)

$

3.14

$

—

Expected life in years

6.0

—

Average expected volatility

75

%

—

Risk-free interest rate

0.95

%

—

Weighted average grant date fair value - ($/share)

$

2.07

$

—

Stock Option Activity

Three Months Ended March 31,

2021

2020

Weighted average exercise price - ($/share)

$

3.14

$

—

Expected life in years

6.0

—

Average expected volatility

75

%

—

Risk-free interest rate

0.95

%

—

Weighted average grant date fair value - ($/share)

$

2.07

$

—

Stock option activity associated with the Monte Carlo model for the three months ended March 31, 2021 is provided below:

Number of Shares Underlying Options

Weighted Average Exercise Price Per Share

Weighted Average Remaining Contractual Term

Aggregate Intrinsic Value

(in thousands)

(in years)

(in thousands)

Outstanding at January 1, 2021

644

1.23

Granted

402

3.14

Exercised

—

—

Unvested shares forfeited

(137)

1.96

Vested shares expired

—

—

Outstanding at March 31, 2021

909

1.96

9.51

$

566

Exercisable at March 31, 2021

—

$

—

—

$

—

Stock option activity associated with the Black-Scholes model for the three months ended March 31, 2021 is provided below:

Number of Shares Underlying Options

Weighted Average Exercise Price Per Share

Weighted Average Remaining Contractual Term

Aggregate Intrinsic Value

(in thousands)

(in years)

(in thousands)

Outstanding at January 1, 2021

1,804

1.38

Granted

—

—

Exercised

(305)

1.13

Unvested shares forfeited

(7)

2.33

Vested shares expired

—

—

Outstanding at March 31, 2021

1,492

1.43

1.68

$

1,248

Exercisable at March 31, 2021

1,323

$

1.31

1.52

$

1,248

Summary of Non Vested Awards

Restricted Stock

Weighted Average Grant Date Fair Value

(in thousands)

Non-vested shares outstanding at January 1, 2021

1,155

$

1.30

Awards granted

526

3.14

Awards vested

(125)

1.37

Awards forfeited

(89)

1.98

Non-vested shares outstanding at March 31, 2021

1,467

$

1.91

SAR Activity

Number of Shares Underlying SARs

Weighted Average Exercise Price Per Share

Term

Aggregate Intrinsic Value

(in thousands)

(in years)

(in thousands)

Outstanding at January 1, 2021

2,940

1.33

Granted

—

—

Exercised

(552)

1.17

Unvested SARs forfeited

(14)

2.33

Vested SARs expired

—

—

Outstanding at March 31, 2021

2,374

1.36

2.02

$

2,151

Exercisable at March 31, 2021

2,027

$

1.23

1.86

$

2,082